Key Congressional Decisions: CR or Omnibus; December or March

Advocacy at a Glance offers you the bullet point summary of current advocacy issues associated with the goals of the Alliance for a Stronger FDA.

• Key Congressional Decisions: CR or Omnibus; December or March. Reportedly, some conservative Republicans are trying to gather sufficient votes to pass a continuing resolution until at least March of 2017. In contrast, many Democrats are pushing for an omnibus bill that would run through December 2016. FDA is more likely to retain proposed funding increases if Congress were to pass omnibus legislation, but prospects are uncertain.

• Califf Publishes on Improving Cardiovascular Outcomes. In a published article in the Journal of the American College of Cardiology, Commissioner Califf reviews opportunities for technology and new evidence generation models to significantly improve outcomes. While focused on Dr. Califf’s expertise in cardiovascular medicine, the article provides insight into how he might look at any area of medical science.